Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Rationally designed antibodies

Rationally designed antibodies

US Patent 8674082 · Granted Mar 18, 2014

Estimated economic value: $315,784,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD30L antibodies and uses thereof2024
Processing reagent and use thereof in assays for detection of analytes associate2019
Rationally designed antibodies2016
Rationally designed antibodies2016
Rationally designed antibodies2016
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and 2016
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and 2015
Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and 2015
Antibodies to OX-2/CD200 and uses thereof2015
Methods for treating chronic lymphocytic leukemia2014
Rationally designed antibodies2014
Rationally designed antibodies2014